What you'll learn
Key ideas from Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
These ideas compress the book's argument without treating the author's view as settled fact. Use them as an orientation before reading the full work or listening in Wiseley.
Early prostate cancer may cause no symptoms, so PSA and rectal examination offer complementary signals with different blind spots.
A concerning PSA calls for confirmation and context, including medications, benign causes, recent procedures, and changes across repeated tests.
Gleason patterns and Grade Groups describe sampled tumor architecture, while clinical stage estimates extent from separate evidence.
Localized disease can lead to surveillance, surgery, or radiation, depending on cancer risk and a person’s priorities and tolerance for uncertainty.
PSA, examination, and MRI inform monitoring, while scheduled repeat biopsies remain important for detecting higher-grade disease.
After prostatectomy, PSA timing, assay sensitivity, and repeated measurements help distinguish a trend from a tiny uncertain reading.
ADT can affect bone, muscle, metabolism, mood, memory, sexual function, and partner intimacy, so monitoring extends beyond PSA.
Sipuleucel-T, checkpoint inhibitors, and PARP inhibitors have distinct roles tied to symptoms and tumor biology.
Inside Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
Read the first chapter in full here. The other 16 continue in the Wiseley app.
Chapter 1 of 17 · 6 min · Audio & text
Prostate Anatomy and Disease Logic
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, by Patrick C. Walsh.
The prostate is a small gland at the meeting point of the urinary and reproductive systems. It sits just below the bladder, encircling the urethra where urine leaves the bladder, with the rectum directly behind it. That position helps explain why the gland can affect urination, ejaculation, and the consequences of treatment. Its best-established role is making fluid for semen. Walsh also notes a proposed protective role: some scientists think prostate secretions may help defend the reproductive tract from infection, but this remains a hypothesis.
The urinary route begins at the kidneys, which make urine. The ureters carry it to the bladder for storage. From there, the urethra passes through the prostate and continues through the penis. The reproductive route joins this pathway near the prostate: the testes make sperm, sperm mature in the epididymis, and the vas deferens carries them toward the prostatic urethra. The seminal vesicles add fluid there. Urine and semen use the urethra at different times; during ejaculation, muscle rings help prevent semen from flowing back into the bladder and direct it outward.
Semen consists of sperm and seminal fluid. About a third of the fluid comes from the prostate and about two-thirds from the seminal vesicles; sperm contributes little to the total volume. The prostate’s fluid and the seminal-vesicle fluid combine with sperm during ejaculation. This makes the gland part of a larger reproductive pathway, even though much of semen’s fluid comes from its neighboring glands.
The prostate has several regions, but two are especially useful for understanding its disorders. The transition zone wraps around the urethra. The peripheral zone lies toward the outside and contains most of the prostate’s glands. These zones help explain why different conditions can produce very different effects, even when they involve the same organ.
Benign prostatic hyperplasia, or BPH, is noncancerous growth that begins in the transition zone. As gland tissue grows and smooth muscle tightens, it can squeeze the urethra. Urination may become frequent, urgent, hesitant, or interrupted; a person may wake at night or feel the bladder has not emptied. Prostate cancer usually begins in the peripheral zone and can grow outward, but it may produce no symptoms for months or years, unlike BPH growth near the urethra, which can cause bothersome urination.
The gland’s activity also responds to androgens, or male hormones. In Walsh’s account, a signal from the hypothalamus prompts the pituitary to release luteinizing hormone, which signals the testes to make testosterone. Prostate cells can convert testosterone into dihydrotestosterone, or DHT, which activates genes in the cells. This helps explain why prostate tissue and prostate cancer respond to androgen signals. Reducing those signals can shrink prostate cancer and delay its progression, although the hormone mechanism is only one part of the disease picture.
The prostate’s neighbors also make treatment consequential. Urinary-control structures sit near the bladder outlet, delicate nerves involved in erections run close to the gland, and the rectum lies just behind it. Removing or treating the prostate can therefore affect continence or erectile function, and nearby rectal tissue can also be harmed. These effects are possible because important structures are crowded together, not because they are all part of the prostate itself.
Pelvic pain and urinary symptoms do not automatically mean there is a bacterial infection. “Prostatitis” is often used broadly, and many men given that label have chronic pelvic pain syndrome, or CPPS, rather than confirmed bacterial disease. CPPS can have different causes and may need different approaches. For example, pelvic-floor muscle spasms can cause tenderness or pain and may respond to specialized physical therapy. Antibiotics do not address symptoms when bacteria are not the cause, and unnecessary courses can create further problems.
A distinct and serious exception is acute bacterial prostatitis. It can bring fever, chills, and severe pain, and may lead to sepsis, urinary retention, or a prostate abscess. A bladder infection can spread to the prostate. This acute illness needs prompt medical attention and antibiotics; inadequate treatment can leave infection behind and allow it to recur as a harder-to-treat chronic infection.
The anatomy provides a practical map: the prostate contributes to semen, surrounds a shared passage, responds to hormones, and sits beside structures that govern urinary and sexual function. Its location helps explain why different prostate conditions behave differently and why treatment effects can extend beyond the gland.
Chapter 2 of 17 · 8 min · Audio & textIn the app
Risk, Inheritance, and Prevention
Cancer begins with changes in a cell’s DNA, but a cancer-related genetic change is not automatically an inherited one. DNA damage happens during normal metabolism and through environmental exposures.
Chapter 3 of 17 · 8 min · Audio & textIn the app
Screening as a Decision Pathway
Early prostate cancer may give no noticeable warning. Symptoms can appear only after a tumor has grown, and urinary changes can also have benign causes.
Chapter 4 of 17 · 11 min · Audio & textIn the app
From Biopsy to Stage
When earlier tests leave enough concern to sample the prostate, a biopsy turns suspicion into evidence from tissue. A needle takes narrow cores for microscopic review.
Chapter 5 of 17 · 6 min · Audio & textIn the app
Choosing Among Initial Paths
Once a cancer’s grade, PSA, and extent are understood, the next question is what kind of care makes sense for this person. There is no single best treatment.
Chapter 6 of 17 · 5 min · Audio & textIn the app
Living with Uncertainty
A diagnosis of prostate cancer changes more than a treatment plan. The book calls survivorship the work of moving forward with life after diagnosis.
Chapter 7 of 17 · 4 min · Audio & textIn the app
Sexual Minority Care
Sexual identity and the kinds of sex a person engages in can shape treatment concerns. For gay and bisexual men, discussing whether they are receptive, insertive, or both can help frame decisions about treatment and recovery.
Chapter 8 of 17 · 7 min · Audio & textIn the app
Active Surveillance in Practice
Active surveillance is a structured way to monitor selected prostate cancers while avoiding or postponing treatment and its possible effects on urinary, bowel, and sexual function. It differs from watchful waiting: surveillance involves regular checks and biopsies so that a change in the cancer can be found and treated.
Chapter 9 of 17 · 9 min · Audio & textIn the app
Radical Prostatectomy and Recovery
Radical prostatectomy removes the prostate to treat cancer that is considered suitable for surgery. Because tumors may be present in more than one place, removing only a visible spot may miss cancer elsewhere in the gland.
Chapter 10 of 17 · 10 min · Audio & textIn the app
External Beam Radiation and Hormones
External-beam radiation is presented as a curative option for localized prostate cancer. Instead of removing the gland, treatment directs radiation into it from outside the body.
Chapter 11 of 17 · 7 min · Audio & textIn the app
Internal Radiation and Focal Treatment
Brachytherapy places radiation sources inside the prostate, allowing a high dose to reach the gland. Permanent seeds stay in place and release radiation over time.
Chapter 12 of 17 · 9 min · Audio & textIn the app
Reading Outcomes and Recurrence
After local treatment, the question is whether cancer control appears durable. Surgery and radiation leave different kinds of evidence, so their results cannot be read in exactly the same way.
Chapter 13 of 17 · 9 min · Audio & textIn the app
Sexual Function after Treatment
Sexual function after prostate treatment is easier to understand when four related experiences are considered separately: desire, erection, ejaculation, and orgasm. Desire is interest in sex.
Chapter 14 of 17 · 8 min · Audio & textIn the app
Hormonal Therapy: Timing and Tradeoffs
Hormonal therapy can slow prostate cancer by reducing the hormones that feed it or blocking the signals those hormones send. It can shrink tumors, lower PSA, and ease symptoms, especially in advanced disease.
Chapter 15 of 17 · 7 min · Audio & textIn the app
Metastatic Disease and Treatment Strategy
Metastatic prostate cancer is not one uniform condition. The term means cancer has spread beyond the prostate; in practice, it usually refers to distant spread, most often to bone.
Chapter 16 of 17 · 11 min · Audio & textIn the app
Matching Advanced Therapies to Tumor Biology
Advanced prostate cancer treatment now reaches beyond lowering testosterone. Some drugs attack dividing cancer cells; others block androgen signals, recruit immune defenses, interfere with DNA repair, or target disease in bone.
Chapter 17 of 17 · 8 min · Audio & textIn the app
Comfort, Coping, and Caregiving
Advanced prostate cancer calls for care that preserves comfort and daily function alongside treatment directed at the tumor. The book describes palliative care as attention to pain, other symptoms, nutrition, and quality of life.
Chapter 1 of 17 · 6 min · Audio & text: Prostate Anatomy and Disease Logic
Wiseley supports reading and listening to summaries in the app.
Continue in Wiseley